Abstract:Stem cell transplantation therapy has provided promising hope for the treatment of a variety of neurodegenerative disorders. Among challenges in developing disease-specific stem cell therapies, identification of key regulatory signals for neuronal differentiation is an essential and critical issue that remains to be resolved. Several lines of evidence suggest that JNK, also known as SAPK, is involved in neuronal differentiation and neural plasticity. It may also play a role in neurite outgrowth during neuronal development. In cultured mouse embryonic stem (ES) cells, we test the hypothesis that the JNK pathway is required for neuronal differentiation. After neural induction, the cells were plated and underwent differentiation for up to 5 days. Western blot analysis showed a dramatic increase in phosphorylated JNKs at 1–5 days after plating. The phosphorylation of JNK subsequently induced activation of STAT1 and STAT3 that lead to expressions of GAP-43, neurofilament, βIII-tubulin, and synaptophysin. NeuN-colabelled with DCX, a marker for neuroblast, was enhanced by JNK signaling. Neuronal differentiation of ES cells was attenuated by treatment with SP600125, which inhibited the JNK activation and decreased the activation of STAT1 and STAT3, and consequently suppressed the expressions of GAP-43, neurofilament, βIII-tubulin, and the secretion of VEGF. Data from immunocytochemistry indicated that the nuclear translocation of STAT3 was reduced, and neurites of ES-derived neurons were shorter after treatment with SP600125 compared with control cells. These results suggest that the JNK-STAT3 pathway is a key regulator required for early neuronal differentiation of mouse ES cells. Further investigation on expression of JNK isoforms showed that JNK-3 was significantly upregulated during the differentiation stage, while JNK-1 and JNK-2 levels decreased. Our study provided interesting information on JNK functions during ES cell neuronal differentiation.

JNK1 and 2 play a negative role in reprogramming to pluripotent stem cells by suppressing Klf4 activity.

Kdm2b Maintains Murine Embryonic Stem Cell Status by Recruiting PRC1 Complex to CpG Islands of Developmental Genes

Histone Demethylases UTX and JMJD3 Are Required for NKT Cell Development in Mice

Inhibition of ERK1/2 Prevents Neural and Mesendodermal Differentiation and Promotes Human Embryonic Stem Cell Self-Renewal.

MAPK8 Regulates Chicken Male Germ Cell Differentiation Through JNK Signaling Pathway.

Pim2 Regulates Stemness Through Phosphorylation of 4E-Bp1

Genome-wide gain-of-function screen identifies novel regulators of pluripotency.

Regulatory Role of the JNK-STAT1/3 Signaling in Neuronal Differentiation of Cultured Mouse Embryonic Stem Cells

JMJD3 Acts in Tandem with KLF4 to Facilitate Reprogramming to Pluripotency.

Klf4 Glutamylation is Required for Cell Reprogramming and Early Embryonic Development in Mice.

Serine 347 Phosphorylation by JNKs Negatively Regulates OCT4 Protein Stability in Mouse Embryonic Stem Cells

CDK1-PDK1-PI3K/Akt signaling pathway regulates embryonic and induced pluripotency

The oncogene c-Jun impedes somatic cell reprogramming

KLF3 promotes the 8-cell-like transcriptional state in pluripotent stem cells

ERK1 and ERK2 Regulate Embryonic Stem Cell Self-Renewal Through Phosphorylation of Klf4

Nucleosome remodeling and deacetylation complex and MBD3 influence mouse embryonic stem cell naïve pluripotency under inhibition of protein kinase C

ERK signalling eliminates Nanog and maintains Oct4 to drive the formative pluripotency transition

ID proteins promote the survival and primed-to-naive transition of human embryonic stem cells through TCF3-mediated transcription

MEK/ERK Signaling Contributes to the Maintenance of Human Embryonic Stem Cell Self-Renewal.

MicroRNA-302 increases reprogramming efficiency via repression of NR2F2.

P21-Activated Kinase 4 Pak4 Maintains Embryonic Stem Cell Pluripotency Via Akt Activation.